Compare Hyperliquid Strategies Inc Common Stock (PURR) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hyperliquid Strategies Inc Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Hyperliquid Strategies Inc Common Stock trades at $11.11 (market cap $2.24B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and Hyperliquid Strategies Inc Common Stock is more actively traded (14,135,020 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold Hyperliquid Strategies Inc Common Stock for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PURR | RLAY | |
|---|---|---|
Market Cap | $2.24B | $3.82B |
Volume | 14,135,020 | 4,332,079 |
Sector | Financials | Health |
52-Week High | $14.09 | $20.75 |
52-Week Low | $3.10 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $2.10B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
